Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Lori

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Molecular Carcinogenesis|December 25, 2018
Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc-driven model of colon cancerGiulia Lori, Paolo Paoli, Angelo Pietro Femia, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 31, 2021
Analytical evaluation of direct bicarbonate measurement with the new gem premier chemstat in hemodialysis patientsFiamma Balboni, Alessandro Terreni, Marco Gallo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 28, 2018
Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking studySergio Hidalgo-Figueroa, Samuel Estrada-Soto, Juan José Ramírez-Espinosa, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2018
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complicationsRosanna Maccari, Antonella Del Corso, Paolo Paoli, et al.
Cells|March 7, 2020
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current PerspectivesMirella Pastore, Giulia Lori, Alessandra Gentilini, et al.
European Journal of Medicinal Chemistry|November 16, 2016
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agentsRosaria Ottanà, Paolo Paoli, Alexandra Naß, et al.
Cell Death Discovery|December 20, 2024
Limiting serine availability during tumor progression promotes muscle wasting in cancer cachexiaErica Pranzini, Livio Muccillo, Ilaria Nesi, et al.
Free Radical Biology & Medicine|April 25, 2025
Secoiridoid-enriched extra virgin olive oil extracts enhance mitochondrial activity and antioxidant response in colorectal cancer cells: The role of Oleacein and Oleocanthal in PPARγ interactionManuela Leo, Caterina Mancini, Giulia Lori, et al.
Cells|May 13, 2026
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer CellsGiulia Lori, Caterina Mancini, Caterina Paffetti, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecular Carcinogenesis|December 25, 2018
Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc-driven model of colon cancerGiulia Lori, Paolo Paoli, Angelo Pietro Femia, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 31, 2021
Analytical evaluation of direct bicarbonate measurement with the new gem premier chemstat in hemodialysis patientsFiamma Balboni, Alessandro Terreni, Marco Gallo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 28, 2018
Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking studySergio Hidalgo-Figueroa, Samuel Estrada-Soto, Juan José Ramírez-Espinosa, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2018
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complicationsRosanna Maccari, Antonella Del Corso, Paolo Paoli, et al.
Cells|March 7, 2020
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current PerspectivesMirella Pastore, Giulia Lori, Alessandra Gentilini, et al.
European Journal of Medicinal Chemistry|November 16, 2016
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agentsRosaria Ottanà, Paolo Paoli, Alexandra Naß, et al.
Cell Death Discovery|December 20, 2024
Limiting serine availability during tumor progression promotes muscle wasting in cancer cachexiaErica Pranzini, Livio Muccillo, Ilaria Nesi, et al.
Free Radical Biology & Medicine|April 25, 2025
Secoiridoid-enriched extra virgin olive oil extracts enhance mitochondrial activity and antioxidant response in colorectal cancer cells: The role of Oleacein and Oleocanthal in PPARγ interactionManuela Leo, Caterina Mancini, Giulia Lori, et al.
Cells|May 13, 2026
Senescent Stroma-Derived Glutamine: A Driver of Aggressiveness in Prostate and Ovarian Cancer CellsGiulia Lori, Caterina Mancini, Caterina Paffetti, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 7, 2019
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cellsAlessandra Gentilini, Alessandra Caligiuri, Chiara Raggi, et al.
Pageof 3